1. Home
  2. EXTR vs BLLN Comparison

EXTR vs BLLN Comparison

Compare EXTR & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Extreme Networks Inc.

EXTR

Extreme Networks Inc.

HOLD

Current Price

$21.72

Market Cap

3.9B

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$126.85

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXTR
BLLN
Founded
1996
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.4B
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
EXTR
BLLN
Price
$21.72
$126.85
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$21.20
★ $126.71
AVG Volume (30 Days)
★ 1.2M
523.3K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 616.67
103.40
EPS
0.31
★ 0.48
Revenue
★ $1,283,593,000.00
$305,112,000.00
Revenue This Year
$13.33
$46.29
Revenue Next Year
$7.97
$30.14
P/E Ratio
★ $69.81
$260.21
Revenue Growth
12.59
★ 99.97
52 Week Low
$13.48
$61.96
52 Week High
$33.73
$150.44

Technical Indicators

Market Signals
Indicator
EXTR
BLLN
Relative Strength Index (RSI) 39.59 59.46
Support Level $21.06 $77.69
Resistance Level $23.16 $150.44
Average True Range (ATR) 0.64 5.60
MACD 0.22 2.24
Stochastic Oscillator 32.80 75.21

Price Performance

Historical Comparison
EXTR
BLLN

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: